Media Room
latest news
AMR life sciences industry 2020 report: Successes and setbacks in fighting superbugs
AMR Industry Alliance reports breakthroughs in the responsible manufacturing of antibiotics and positive steps to improve how patients access and use antibiotics. But its report also highlights conc...
Read more
AMR Industry Alliance Round-Up, Issue No.3, November 2019
Welcome to the third issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as p...
Read more
AMR Industry Alliance Round-Up, Issue No.2, September 2019
Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as...
Read morefrom the blog
US FDA report finds economic forces at the root of generic antibiotic shortages
Generic antibiotics underpin recommended prescribing guidance for most infections, accounting for between 80% and 90% of prescriptions in primary healthcare worldwide. However, increasing costs and in...
Read more
The new reality for next-gen antibiotics
The future of antibiotic development lies in targeted approaches that can deliver novel drugs tailored to tackle those highly resistant pathogens with greatest medical need. The world of antibacte...
Read more
Putting the brakes on AMR in India
India’s ban on colistin in the animal food industry marks a critical move against AMR in the country; one that should go hand in hand with a stringent crackdown on inappropriate use in human medicin...
Read morein the press
Companies must responsibly manufacture the antimicrobials society needs
This article was first published in STAT on 30 January 2020 by Steve Brooks and Alba Tiley In a world challenged by microbes resistant to antibiotics, many medical interventions that rely on the...
Read more
Manufacturers of new antibiotics go bankrupt
700,000 people die from drug-resistant infections – so why do antibiotic companies face bankruptcy? This article was first published in the NZZamSonntag on 26 January 2020 by Birgit Voigt The...
Read more
The Fight Against Superbugs: Properly Incentivising Antimicrobial R&D Is Key
This article was published in Pharma Boardroom on 16 January 2020. Opinion by Greg Frank. Drug-resistant superbugs are evolving at a rapid pace. In fact, it is estimated that 700,000 people die fr...
Read more